MCLN, APDN, RNTL, PURE, ABHI, CDOI
Our Stocks to Watch tomorrow include MedClean Technologies Inc. (OTCBB: MCLN), Applied DNA Sciences Inc. (OTCBB: APDN), Rockwood National Corp. (OTC: RNTL), Pure Bioscience Inc. (NASDAQ: PURE), AmbiCom Holdings Inc. (OTC: ABHI) and Cardio Infrared Technologies Inc. (OTC: CDOI).
MEDCLEAN TECHNOLOGIES INCORPORATED (OTCBB: MCLN)
"Up 100.00% on Thursday"
Detailed Quote: http://www.otcpicks.com/quotes/MCLN.php
MedClean Technologies, Inc. is a provider of innovative technology and services for the treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable healthcare providers and medical waste haulers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities now located in Bethlehem, Pennsylvania.
No recent news for MedClean Technologies Inc. (OTCBB: MCLN).
APPLIED DNA SCIENCES INCORPORATED (OTCBB: APDN)
"Up 22.32% on Thursday"
Detailed Quote: http://www.otcpicks.com/quotes/APDN.php
APDN sells patented DNA security solutions to protect products, brands and intellectual property from counterfeiting and diversion. SigNature DNA is a botanical mark used to authenticate products in a unique manner that essentially cannot be copied. APDN also provides BioMaterial GenoTyping™ by detecting genomic DNA in natural materials to authenticate finished products. Both technologies protect brands and products in a wide range of industries and provide a forensic chain of evidence that can be used to prosecute perpetrators.
August 16 - Defense Logistics Agency Mandates SigNature® DNA on Microchips
Applied DNA Sciences Supplies Department of Defense in Battle Against Counterfeits
Applied DNA Sciences, Inc. (OTCBB: APDN), a provider of DNA-based anti-counterfeiting and security solutions has been named by DoD Defense Logistics Agency (DLA), as the provider of authentication services for microcircuits supplied by defense contractors. On August 3, 2012, DLA posted notice on its DLA Internet Bid Board System (DIBBS) that it will require the use of SigNature® DNA marking on microcircuits.
"DLA is implementing new requirements for deoxyribonucleic acid (DNA) authentication marking on items falling within Federal Supply Class (FSC) 5962, Electronic Microcircuits, which have been determined to be at high risk for counterfeiting. A new clause at Defense Logistics Acquisition Directive (DLAD) 52.211-9074, Deoxyribonucleic Acid (DNA) Marking on High Risk Items, will be included in new solicitations and contracts for FSC 5962 items when the item description states that the item requires DNA marking. The clause requires contractors to provide items that have been marked with botanically-generated DNA produced by Applied DNA Sciences or its authorized licensees, if any."
The number of companies directly affected by the DLA directive is in the hundreds, and includes many of the largest microcircuit manufacturers in the world. APDN reported immediate inquiries from numerous impacted companies.
SigNature DNA uses uncopyable plant-based DNA to mark items, which can then be authenticated throughout the supply chain to assure originality. In effect, the DNA marks provide a traveling, high-tech proof of authenticity.
Applied DNA Sciences' SigNature DNA marking and authentication have been tested at full commercial scale in an eighteen-month project supported by DLA and managed by the not-for-profit consultancy LMI, with uniformly successful results. As part of the project, DLA tasked an independent laboratory to defeat the technology. SigNature DNA was not defeated.
"Finding counterfeits in supply chains is a daunting challenge. DLA is taking a leadership role by mandating a positive way to assure authenticity using SigNature DNA. Warfighter support is DLA's top priority." Janice Meraglia, Vice President of Government and Military Programs at APDN praised the Agency's efforts to eliminate counterfeit microelectronics from military supply chains.
APDN will sell SigNature DNA marks to chip manufacturers, while for distributors the company will sell a source-verification marking program, to establish traceability from the moment of marking. The company also plans to provide DNA marking services directly to those manufacturers who want immediate implementation before establishing marking capability at their own facilities. Once SigNature DNA-marked, the microchips may be authenticated as originals at any stage along the military supply chain, if a participating company has purchased an authentication program from APDN.
Defense contractors are urged to contact Applied DNA Sciences immediately to begin their own SigNature DNA marking program. A dedicated email address
is available to support this effort. By phone, enquiries are welcome at a dedicated telephone line: 631.444.6370.
The SigNature DNA marking initiative by DLA comes at a critical juncture for the electronics industry, which is facing a new federal law that would strictly enforce new anti-counterfeiting measures by defense contractors. The legal wording of the anti-counterfeiting initiative is found in Section 818 of the National Defense Authorization Act for Fiscal Year 2012 (FY'12 NDAA). While the DLA mandate is not directly connected to the new measures called for by Section 818, it applies in an environment where defense contractors are being strongly urged in various ways to adopt new processes and technologies to combat fakes sneaking into military equipment.
Section 818 of FY'12 NDAA is due to reach an important milestone at the end of September. At that time the law directs that the Defense Federal Acquisition Regulation Supplement (DFARS), which governs all transactions with DoD, is due to be revised to include the anti-counterfeiting provisions. This highly anticipated milestone has been characterized in a public open letter from the Council of Defense and Space Industry Associations as a law that will "fundamentally change the nature of the existing global supply chain for the defense industrial base."(1)
The DoD Office of the Director, Cost Assessment and Program Evaluation last year projected the value of all semiconductors sold to DoD in fiscal year 2011 to be $3.1 billion. The figure for fiscal year 2012 is projected to be $2.84 billion.(2) These figures include both microchips sold stand-alone ("direct sales") for spare parts or prototyping, and also microchips that are embedded in more complex electronic parts sold to the military ("indirect sales"). Indirect sales may range from amplifiers, to computers to aircraft and missile guidance systems.
The market value of semiconductors, both military and commercial in all countries in fiscal year 2011 has been estimated at $302 billion by Gartner.(3)
The DLA mandate for SigNature DNA will be implemented in a staged fashion, to ensure a smooth transition for the industry providers of microcircuits falling into FSC 5962, as noted by DLA. In the first stage, already accomplished and consistent with the mandate, SigNature DNA is on the microchips produced in the DLA's Generalized Emulation of Microcircuits (GEM) program.
The penetration of counterfeit electronics into the military has become a recognized national security crisis. In a Senate Armed Services Committee hearing last November, co-chaired by Senator Carl Levin (D-Mich) and Senator John McCain (R-Ariz), 1,800 separate "counterfeit incidents" in the military were identified. Each incident can involve thousands of parts. The Committee identified more than a million counterfeit parts in all.
In the military, load-bearing parts like ball-bearings, and other critical parts such as o-rings and brake shoes, are widely counterfeited and create much risk. In the commercial sector, fake medical and automotive parts are common, creating a comparable threat. Applied DNA believes that the risk in these areas can also be strongly mitigated by the use of SigNature DNA.
Dr. James A. Hayward, CEO of APDN, stated: "We commend the foresight of DLA command. This is an overdue, industry-changing moment that will protect our warfighters. APDN is fully prepared to meet this challenge."
ROCKWOOD NATIONAL CORPORATION (OTC: RNTL)
"Up 333.33% on Thursday"
Detailed Quote: http://www.otcpicks.com/quotes/RNTL.php
Rockwood National Corporation operates as a real estate services organization in the United States. It offers default loss mitigation, real estate brokerage, mortgage lending, and title insurance services. The company, through its subsidiary, Elite Home Loans, offers mortgage lending services on a national level. Rockwood National Corporation is based in Boca Raton, Florida.
No recent news for Rockwood National Corporation (OTC: RNTL).
PURE BIOSCIENCE INCORPORATED (NASDAQ: PURE)
"Up 19.07% on Thursday"
Detailed Quote: http://www.otcpicks.com/quotes/PURE.php
Pure Green, LLC is the international distributor of PureGreen24 disinfectant and deodorizer. Pure Green is dedicated to reducing health risks caused by exposure to pathogens without endangering humans and animals during the disinfecting process. PureGreen24 kills MRSA and Staph, yet also kills common household germs and provides 24-hour effectiveness against standard bacteria. PureGreen24 can be used in the presence of children and animals.
August 14 - PURE Bioscience Announces 1-for-8 Reverse Stock Split
PURE Bioscience, Inc. (NASDAQ: PURE), the creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced it has finalized a reverse stock split. As previously announced in a news release dated August 1, 2012, Pure Bioscience’s stockholders approved a reverse stock split at the Company’s annual meeting of stockholders convened July 31, 2012. The Company’s Board of Directors was authorized to proceed with an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split and determine the effective date of the reverse split and the ratio of the split within a range of no less than 1-for-4 or greater than 1-for-10.
The Board of Directors has determined to fix the ratio for the reverse stock split at 1-for-8, with an expected effective date to be following the close of the market today, and trading on a post-reverse split-adjusted basis on the NASDAQ Capital Market to begin as of the opening of trading on August 15, 2012. The Company’s common stock will continue to be reported on the NASDAQ Capital Market under the symbol “PURE” (although NASDAQ will likely add the letter “D” to the end of the trading symbol for a period of 20 trading days to indicate that the reverse stock split has occurred). The common stock will have a new CUSIP number (74621T 209) upon the reverse stock split becoming effective.
Upon the effectiveness of the reverse stock split, each eight (8) shares of the Company’s issued and outstanding common stock will be automatically combined and converted into one (1) issued and outstanding share of common stock, par value $0.01 per share. The reverse stock split will affect all issued and outstanding shares of the Company’s common stock, as well as common stock underlying stock options, warrants, and convertible notes outstanding immediately prior to the effectiveness of the reverse stock split. The reverse stock split will reduce the number of outstanding shares of the Company’s common stock currently outstanding from approximately 57.8 million to approximately 7.2 million. The number of authorized shares of the Company’s common stock will not be affected by the reverse stock split.
No fractional shares will be issued in connection with the reverse split of the issued and outstanding common stock. Stockholders who would otherwise hold a fractional share of the Company’s common stock will receive a cash payment in lieu of such fractional share based on the average closing price of the common stock on the NASDAQ Capital Market for the five trading days prior to the effective date of the reverse stock split.
Stockholders with shares held in book-entry form or through a bank, broker, or other nominee are not required to take any action and will see the impact of the reverse stock split reflected in their accounts after August 15, 2012. Beneficial holders may contact their bank, broker, or nominee for more information. Stockholders with shares held in certificate form are required to exchange their stock certificates for book-entry shares representing the shares of common stock resulting from the reverse stock split. Shortly after August 15, 2012, registered holders who hold stock in certificate form will receive a Letter of Transmittal and instructions for exchanging their certificates from the Company’s transfer agent, Computer Share.
AMBICOM HOLDINGS INCORPORATED (OTC: ABHI)
"Up 85.48% on Thursday"
Detailed Quote: http://www.otcpicks.com/quotes/ABHI.php
AmbiCom is headquartered in Milpitas, California, and is a leading designer and developer of wireless products focusing on the wireless medical industry. The Company's wireless modules and devices are based on the Company's innovative application software for both WiFi and Bluetooth technologies. AmbiCom is committed to wireless design and development of software and hardware, and to bringing new and innovative products to the wireless medical markets and other sectors. AmbiCom also serves as a distributor for innovative healthcare products both in the US and abroad. The Company plans to grow organically, and to augment that growth by selectively acquiring complementary products and technologies via acquisition opportunities deemed to be of strategic value.
No recent news for AmbiCom Holdings, Inc. (OTC: ABHI).
CARDIO INFRARED TECHNOLOGIES INCORPORATED (OTC: CDOI)
"Up 100.00% on Thursday"
Detailed Quote: http://www.otcpicks.com/quotes/CDOI.php
Cardio Infrared Technologies, Inc. is a technology and marketing company, which is focused on developing the revolutionary and evolutionary process of combining exercise equipment with medical benefits that go far beyond the normal benefits of standard exercise equipment. Cardio Infrared Technologies, Inc. is committed to continue to market this equipment to the exercise and medical markets and to aggressively expand the market into every country around the world. The technology has been featured on Good Morning America and The View. Cardio Infrared Technologies, Inc. also has an aggressive growth plan that includes mergers and acquisitions and the development of innovative new equipment and programs within the exercise and medical industries.
No recent news for Cardio Infrared Technologies, Inc. (OTC: CDOI).